FDA Releases Draft Guidance for Nucleic Acid-Based In Vitro Diagnostic Devices for Tuberculosis Detection

Summary

The FDA has published a draft guidance document to support the reclassification of devices for detecting tuberculosis from class III to class II, aiming to aid in the diagnosis of pulmonary tuberculosis